BIOQ Stock: Bioqual, Inc. Stock Price, Analysis & Insights
Get live BIOQ stock price $32.50, comprehensive Bioqual, Inc. stock analysis, charts, news, and expert forecast. Real-time BIOQ stock data and investment insights.
Loading chart data...
Bioqual, Inc. (BIOQ) Overview
Bioqual, Inc. (BIOQ) is a publicly traded company in the Healthcare sector , specifically within the Medical - Diagnostics & Research industry . As of the latest trading session, BIOQ trades at $32.50 with a market capitalization of 29.07M . Over the past 52 weeks, BIOQ has traded between $32.50 and $44.25 , with the current price positioned at approximately 0% of this range . The stock current...
Key Takeaways
- Operates in the Healthcare sector (Medical - Diagnostics & Research)
- Market cap: 29.07M
- Current price: $32.50
- 52-week range: $32.50 - $44.25
- P/E ratio: 15.85
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Bioqual, Inc. delivers a range of preclinical research solutions, encompassing both in-vivo and in-vitro methodologies, to its diverse clientele of commercial enterprises and government agencies across the United States. Their expertise spans numerou...
Company Information
- CEO
- Hanne Andersen-Elyard
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Employees
- 278
Contact Information
- Website
- https://www.bioqual.com
- Address
- 9600 Medical Center Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 15.8)
✓ Lower volatility stock (Beta: -0.11) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Bioqual, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Bioqual, Inc.
- ⚠Investors should consider how Bioqual, Inc. fits within their overall portfolio allocation
Market Cap
29.07M
P/E Ratio (TTM)
15.85
Beta
-0.11
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare BIOQ with peer companies:
- Price
- $0.03
- Market cap
- 14.48M
- Price
- $0.95
- Market cap
- 127.22M
- Price
- $0.22
- Market cap
- 54.17M
- Price
- $0.00
- Market cap
- 88.89K
- Price
- $0.37
- Market cap
- 41.68M
- Price
- $0.01
- Market cap
- 8.49M
- Price
- $0.48
- Market cap
- 34.77M
- Price
- $0.06
- Market cap
- 29.88M
- Price
- $0.11
- Market cap
- 38.25M
- Price
- $0.17
- Market cap
- 49.76M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.